A remitted patient with ARFID faces panic after a crash, showing why recovery includes somatic fear, not just eating behavior.
|Videos|October 23, 2020
The Icelandic Mutation
Author(s)Susan Catalano, PhD
Dr Susan Catalano of Cognition Therapeutics talks the science behind the Icelandic Mutation and their potential upcoming drug for the treatment of Alzheimer disease.
Advertisement
Dr Catalano is the co-founder and chief science officer at
Advertisement
Related to this article
Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
Once-monthly subcutaneous olanzapine TEV-749 shows sustained stabilization and remission in schizophrenia, supports direct switching, and avoids post-injection monitoring.
Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
Explore PTSD prevalence, comorbidities, and first-line care as we invite clinicians to share cases and research.
Veterans younger than 30 starting antidepressants, and anyone coprescribed opioids and benzodiazepines, will need to sign consent forms starting in 2027.
How genes and early stress interact to shape antisocial behavior, from dopamine and serotonin pathways to MAOA and oxytocin findings.
Policy shifts have opened the door to telehealth buprenorphine for pregnant and postpartum women with OUD, but research, guidelines, and state policy lag behind.
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Clinicians Need to Know About Postpartum Psychosis
2
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
3
Post Hoc SOLARIS Data Support Stabilization and Remission With Subcutaneous Olanzapine
4
Real-World Evidence and Long-Term Data for Lybalvi and Aristada
5